Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria
- 1 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 14 (7) , 1112-1119
Abstract
Rationale: The mortality of patients with respiratory tract isolates of nontuberculous mycobacteria (NTM) and their risk factors for death are not well described. Objectives: To determine age-adjusted mortality rates for patients with respiratory NTM isolates and their causes of death and to examine whether American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) diagnostic criteria identify those at higher risk of death after NTM isolation. Methods: We linked vital records registries with a previously identified Oregon population–based cohort of patients with NTM respiratory isolation. We excluded patients with Mycobacterium gordonae (n = 33) and those who died (n = 21) at the time of first isolation. We calculated 5-year age-adjusted mortality rates. We used Kaplan-Meier and Cox proportional hazards analysis to examine the association of ATS/IDSA criteria and other risk factors with death. Results: Of 368 subjects with respiratory NTM isolates in 2005–2006, 316 were included in the survival analysis. Most (84%) of their cultures isolated Mycobacterium avium complex. 35.1% died in the 5 years following respiratory isolation. Five-year age-adjusted mortality rates were slightly higher for those meeting (28.7/1,000) versus not meeting (23.4/1,000) ATS/IDSA criteria. In multivariate analysis, older age (adjusted hazard ratio [aHR], 1.06; 95% confidence interval [CI], 1.04–1.07) and lung cancer (aHR, 2.77; 95% CI, 1.51–5.07) were associated with an increased risk of death. A trend was noted between meeting ATS/IDSA criteria and subsequent death (aHR, 1.37; 95% CI, 0.95–1.97). Among cases, male sex, older age, and immunosuppressive therapy use were independent risk factors for death. Conclusions: In the State of Oregon, patients with NTM respiratory isolates have high mortality, regardless of whether they meet ATS/IDSA criteria for pulmonary NTM disease. Most patients die as a result of causes other than NTM infection.Keywords
This publication has 27 references indexed in Scilit:
- Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012Annals of the American Thoracic Society, 2015
- Prognostic Factors and Radiographic Outcomes of Nontuberculous Mycobacterial Lung Disease in Rheumatoid ArthritisThe Journal of Rheumatology, 2013
- Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare BeneficiariesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex diseaseThe International Journal of Tuberculosis and Lung Disease, 2012
- Isolation Prevalence of Pulmonary Nontuberculous Mycobacteria in Ontario in 2007Canadian Respiratory Journal, 2011
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery SystemsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Clinical course and prognosis of patients with chronic obstructive pulmonary diseaseCurrent Opinion in Pulmonary Medicine, 2000
- Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe PatternChest, 1992
- Prognosis in Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1986